Latest Non-steroidal anti-inflammatory drugs Stories

NEWPORT, Ky., June 17 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for Zipsor (diclofenac potassium) Liquid Filled Capsules, a new treatment option indicated for relief of mild to moderate acute pain in adults (18 years of age or older). "Zipsor is a drug with several unique features," said Gary A. Shangold, Chief Medical Officer of Xanodyne. "It is the first NSAID to be approved based on the...

The U.S. Food and Drug Administration has approved Caldolor, the first injectable form of ibuprofen, to treat pain and fever in hospitals. Injectable ibuprofen and other non-steroidal anti-inflammatory drugs are promising pain management options, said Dr. Bob Rappaport, director of the FDA's Division of Anesthesia, Analgesia and Rheumatology Drug Products. But until now there were only oral forms of most NSAIDs. An injectable ibuprofen product can provide patients with relief from pain and...

New drug is first injectable product approved for sale in the United Statesfor treatment of pain and fever NASHVILLE, Tenn., June 11 /PRNewswire/ -- Cumberland Pharmaceuticals (www.cumberlandpharma.com) today announced the U.S. Food and Drug Administration (FDA) has approved Caldolor(TM), an intravenous formulation of ibuprofen, through a priority review. Caldolor is the first and only injectable product approved for sale in the United States for the treatment of both pain and fever....

HARBIN, China, June 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it obtained approval from the State Food and Drug Administration (SFDA) in China for the production of Diclofenac Sodium eye drops. The document number for the drug is 2009S02063. Diclofenac Sodium...

--Data from Phase 3 REDUCE-1 and REDUCE-2 Studies Demonstrate that Novel Combination Treatment Decreases Risk of Developing GI Ulcers by Approximately 50 Percent-- --Data presented today at 56th Annual Digestive Disease Week Meeting in Chicago-- CHICAGO, June 1 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today presented data at the 56th Annual Digestive Disease Week (DDW) meeting from two pivotal Phase 3 trials evaluating its lead compound...

- Webinar on June 9 to discuss the prevalence and prevention of NSAID-induced ulcers available at www.connecttoprotect.com - BETHESDA, Md. and CHICAGO, June 1 /PRNewswire/ -- The American Gastroenterological Association (AGA) Institute and Horizon Therapeutics, Inc. today launched Connect to Protect, a program to increase awareness about the gastrointestinal (GI) risks associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen. Connect to...

UK researchers say that low-dose aspirin should not routinely be used to prevent heart attacks and strokes, contrary to official guidance.Data from over 100,000 clinical trial participants was analyzed and it was found that the risk of harm largely cancelled out the benefits of taking the drug.They found that only those who have already had a heart attack or stroke should be advised to take a daily aspirin.GPs said that the Lancet study would help to clarity a "confusing" issue.The...

SAN DIEGO, May 26 /PRNewswire/ -- Medinox, Inc. (Carlsbad, CA) and its development partner, Logical Therapeutics, Inc. (Waltham, MA) announced the results of a double-blind, randomized, active comparator study of LT-NS001 (formerly MX-1094) vs naproxen, in subjects 45 to 70 years of age. LT-NS001 is a novel, patented NCE prodrug of the popular non-steroidal anti-inflammatory drug (NSAID) naproxen, which is being developed to significantly reduce the GI safety risks, including the formation...

If you need aspirin to work fast, a U.S. researcher says chewable aspirin shows greater and more rapid absorption. Dr. Sean Nordt of the University of California in San Diego gave three types of aspirin to a group of volunteer research subjects: regular aspirin swallowed whole, regular aspirin chewed and swallowed and chewable aspirin chewed and swallowed. Nordt, the study leader, tested blood levels of aspirin to see which route led to the highest aspirin levels in the body. The chewable...

For many years, it has been known that aspirin is beneficial to patients suffering heart attacks and near-heart attacks. But which of the many different types of aspirin is likely to help the most?A group of researchers led by Dr. Sean Nordt from the University of California, San Diego gave three different types of aspirin to a group of volunteer research subjects: regular aspirin swallowed whole, regular aspirin chewed and swallowed, and chewable aspirin chewed and swallowed. Blood levels of...